Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 44-50 , January 2010

Abnormal aortic elasticity in patients with liver steatosis

  • Zafer Işılak

      Affiliations

    • GATA Haydarpaşa Teaching Hospital, Department of Cardiology, Istanbul, Turkey
    • ,
  • Mustafa Aparcı

      Affiliations

    • Air Force Academy Hospital, Cardiology Service, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 505 394 71 31; fax: +90 212 233 44 56.
    • ,
  • Ejder Kardeşoğlu

      Affiliations

    • GATA Haydarpaşa Teaching Hospital, Department of Cardiology, Istanbul, Turkey
    • ,
  • Ömer Yiğiner

      Affiliations

    • GATA Haydarpaşa Teaching Hospital, Department of Cardiology, Istanbul, Turkey
    • ,
  • Ömer Uz

      Affiliations

    • GATA Haydarpaşa Teaching Hospital, Department of Cardiology, Istanbul, Turkey
    • ,
  • Onur Sildiroglu

      Affiliations

    • GATA Haydarpaşa Teaching Hospital, Department of Radiology, Istanbul, Turkey
    • ,
  • Namık Özmen

      Affiliations

    • GATA Haydarpaşa Teaching Hospital, Department of Cardiology, Istanbul, Turkey
    • ,
  • Murat Yalçın

      Affiliations

    • Izmir Military Hospital, Cardiology Service, Izmir, Turkey
    • ,
  • Bekir Yılmaz Cingözbay

      Affiliations

    • GATA Haydarpaşa Teaching Hospital, Department of Cardiology, Istanbul, Turkey
    • ,
  • Bekir Sıtkı Cebeci

      Affiliations

    • GATA Haydarpaşa Teaching Hospital, Department of Cardiology, Istanbul, Turkey

Received 20 April 2009 ,Revised 15 October 2009 ,Accepted 19 October 2009.

References 

  1. Targher G, Bertolini L, Padova R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30:1212–1218
  2. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 1999;107:450–455
  3. Akahoshi M, Amasaki Y, Soda M, Tominaga T, Ichimaru S, Nakashima E, et al. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. Hypertens. Res. 2001;24:337–343
  4. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care. 2004;27:2498–2500
  5. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis. A case-control study. Arterioscler. Thromb. Vasc. Biol. 2005;25:1045–1050
  6. Lautamäki R, Bora R, Iozzo P, Komu M, Lehtimäki T, Salmi M, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2006;291:282–290
  7. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type2 diabetic patients. Diabetes. 2005;54:3541–3546
  8. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr. Opin. Lipidol. 2005;16:421–427
  9. Cameron JD, Jennings GL, Dart AM. The relationship between arterial compliance, age, blood pressure and serum lipid levels. J. Hypertens. 1995;13:1718–1723
  10. Wada T, Kodaira K, Fujishiro K, Maie K, Tsukiyama E, Fukumoto T, et al. Correlation of ultrasound-measured common carotid artery stiffness with pathological findings. Arterioscler. Thromb. Vasc. Biol. 1994;14:479–482
  11. Lehmann ED, Gosling RG, Sonksen PH. Arterial wall compliance in diabetes. Diabet. Med. 1992;9:114–119
  12. Lacombe F, Dart A, Dewar E, Jennings G, Cameron J, Laufer E. Arterial elastic properties in man: a comparison of echo-Doppler indices of aortic stiffness. Eur. Heart J. 1992;13:1040–1045
  13. McGahan JP, Goldberg BB. Diagnostic Ultrasound. New York: Informa Healthcare; 2008;
  14. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750
  15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Developed in conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 2005;18:1440–1463
  16. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke. 2001;32:454–460
  17. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive. Patients Hypertens. 1999;33:1111–1117
  18. Darné B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional and prospective analysis on cardiovascular mortality. Hypertension. 1989;13:392–400
  19. Nickenig G, Sachinidis A, Michaelsen F, Böhm M, Seewald S, Vetter H. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation. 1997;95:473–478
  20. Matsuo S, Nakamura Y, Yamada T, Uchida Y, Nakae I, Horie M. Effect of statin therapy on arterial stiffness in patients with hyperlipidemia: Shiga Pravastatin Atherosclerosis Study (SHIPAS) Group. J. Appl. Res. 2005;5(2):397–401
  21. Avolio AP, Chen S, Wang R, Zhang C, Li M, O’Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation. 1983;68:50–58
  22. Alper AT, Hasdemir H, Şahin S, Öntürk E, Akyol A, Nurkalem Z, et al. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Arch. Turk. Soc. Cardiol. 2008;36(6):376–381
  23. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002;346:1221–1231
  24. Mullenix PS, Andersen CA, Starnes BW. Atherosclerosis as inflammation. Ann. Vasc. Surg. 2005;19:130–138
  25. Knuuti MJ, Maki M, Yki-Jarvinen H, Voipio-Pulkki LM, Harkonen R, Haaparanta M, et al. The effect of insulin and FFA on myocardial glucose uptake. J. Mol. Cell. Cardiol. 1995;27:1359–1367
  26. Julius S, Valentini M, Palatini P. Overweight and hypertension: a 2-way street?. Hypertension. 2000;35:807
  27. Hozawa A, Ohkubo T, Kikuya M, Ugajin T, Yamaguchi J, Asayama K, et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am. J. Hypertens. 2004;17(11):1005–1010
  28. Mureddu GF, Greco R, Rosato GF, Cella A, Vaccaro O, Contaldo F, et al. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity. Int. J. Obesity. 1998;22:363–368
  29. Roes SD, Dehnavi RA, Westenberg JJM, Lamb HJ, Mertens BJA, Tamsma JT, et al. Assessment of aortic pulse wave velocity and cardiac diastolic function in subjects with and without the metabolic syndrome. Diabetes Care. 2008;31:1442–1444
  30. Kopel L, Tarasoutchi F, Medeiros C, Carvalho RT, Grinberg M, Lage SG. Arterial distensibility as a possible compensatory mechanism in chronic aortic regurgitation. Arq. Bras. Cardiol. 2001;77(3):262–265
  31. Wainai Y. Adaptive mechanisms of the aorta and left ventricle to volume overloading following abrupt aortic regurgitation in rabbits. Cardiovasc. Res. 1991;25:463–467
  32. Samaras K, McElduff A, Twigg SM, Proietto J, Prins JB, Welborn TA, et al. Insulin levels in insulin resistance: phantom of the metabolic opera?. MJA. 2006;185(3):159–161
  33. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N. Engl. J. Med. 2001;344:495–500
  34. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2008;28(1):27–38

PII: S0168-8227(09)00434-3

doi: 10.1016/j.diabres.2009.10.009

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 44-50 , January 2010

Article Tools